mHealth Monitoring of Treatment of Cutaneous Leishmaniasis Patients: A Community-Based Implementation Study
Authors:
- Alexandra CossioACAlexandra Cossio
- Martha Milena Bautista-GomezMBMartha Milena Bautista-Gomez
- Neal AlexanderNANeal Alexander
- Alejandra María del CastilloACAlejandra María del Castillo
- María del Mar CastroMCMaría del Mar Castro
- Patricia Yaneth Castaño-GrajalesPCPatricia Yaneth Castaño-Grajales
- Yeison Hawer Gutiérrez-PolocheYGYeison Hawer Gutiérrez-Poloche
- Laura Sofía ZuluagaLZLaura Sofía Zuluaga
- Leonardo Vargas-BernalLVLeonardo Vargas-Bernal
- Andrés NavarroANAndrés Navarro
- Nancy Gore SaraviaNSNancy Gore Saravia
Open Access
- 4 October 2023
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 109 (4) , 778-790
Abstract
: Cutaneous leishmaniasis (CL) remains a global health problem. Compelled by the protracted healing process, initial and final outcomes of treatment are determined at 90 and 180 days, respectively, after initiation of treatment. Loss to follow-up during these intervals is substantial. Consequently, the effectiveness of treatment is largely unknown. We conducted an effectiveness-implementation hybrid design study of a community-based mobile health (mHealth) strategy to monitor adherence to anti-leishmanial treatment, adverse drug reactions, and therapeutic response compared with standard of care in two rural communities of Colombia. Three implementation outcomes were evaluated: usability and acceptability by qualitative methods and fidelity using quantitative methods. Fifty-seven patients were prospectively included in the mHealth intervention and 48 in the standard-of-care group. In addition, 24 community health leaders (CHLs), health workers, and patients participated in qualitative evaluations. The intervention significantly increased the proportion of patients having follow-up of therapeutic outcomes 90 and 180 days after initiating treatment from 4.2% (standard of care) to 82.5% (intervention), P < 0.001. The proportion of patients having records of treatment adherence, adverse drug reactions, and therapeutic response also increased significantly (P < 0.001). Fidelity to the intervention (recording of treatment adherence, adverse drug reactions, lesion photographs, and evaluation of therapeutic response) was 70–100%. The app was highly accepted by CHLs, health workers, and patients, who perceived that the app improved case identification and follow-up and met a public health need. Although usability was high, low connectivity affected real-time transmission of data. This community-based mHealth strategy facilitated access to health care for CL in rural areas and knowledge of treatment effectiveness.Keywords
This publication has 49 references indexed in Scilit:
- Usability evaluation of mobile applications using ISO 9241 and ISO 25062 standardsSpringerPlus, 2016
- Evidence on feasibility and effective use of mHealth strategies by frontline health workers in developing countries: systematic reviewTropical Medicine & International Health, 2015
- Republished research: Implementation research: what it is and how to do itBritish Journal of Sports Medicine, 2014
- Implementation research: what it is and how to do it.2013
- Community Health Workers and Mobile Technology: A Systematic Review of the LiteraturePLOS ONE, 2013
- Methodology of Clinical Trials Aimed at Assessing Interventions for Cutaneous LeishmaniasisPLOS Neglected Tropical Diseases, 2013
- Effectiveness-implementation Hybrid DesignsMedical Care, 2012
- Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New WorldActa Tropica, 2011
- Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research AgendaAdministration and Policy in Mental Health and Mental Health Services Research, 2010
- Confidence intervals that match Fisher's exact or Blaker's exact testsBiostatistics, 2009